Nucleotide receptors stimulation by extracellular ATP controls Hsp90 expression through APE1/Ref-1 in thyroid cancer cells: A novel tumorigenic pathway

作者: Alex Pines , Nicoletta Bivi , Carlo Vascotto , Milena Romanello , Chiara D'Ambrosio

DOI: 10.1002/JCP.20704

关键词:

摘要: Nucleotide receptors signaling affects cell proliferation, with possible implications on tumorigenic processes. However, molecular targets and action mechanisms of the extracellular nucleotides are still poorly elucidated. We have previously shown in ARO cells that APE1/Ref-1, a transcriptional coactivator responsible for maintenance cellular proliferative rate, is functionally controlled by P2-mediated signaling. Here, we demonstrate ATP has mitogenic effect cells, increasing ERK phosphorylation, AP1 activation, cyclin D1 expression. Using ATP/ADPase apyrase P2 receptor antagonist suramin, show ATP, physiologically released exerts effects. A differential proteomic approach was used to identify events associated ATP-induced proliferation. Among other proteins, Hsp90 found upregulated upon stimulation. Pretreatment suramin completely blocked confirming involvement cell-surface nucleotide ATP-mediated activation cells. Treatment proliferating significantly reduced intracellular levels Hsp90, suggesting an autocrine/paracrine mechanism control expression ATP. The influence proliferation also demonstrated its specific inhibition 17-AAG. pathway which stimulates further investigated siRNA strategies showing target APE1/Ref-1 functional activation. Stimulation agonists evidenced major P2Y1 P2Y2 controlling Accordingly, these two resulted sample biopsies from different thyroid tumors. J. Cell. Physiol. 209: 44–55, 2006. © 2006 Wiley-Liss, Inc.

参考文章(52)
J. T. Neary, M. P. Abbracchio, Trophic Roles of Purines and Pyrimidines Handbook of experimental pharmacology. ,vol. 151, pp. 305- 338 ,(2001) , 10.1007/978-3-662-09604-8_11
David Erlinge, Extracellular ATP: A Growth Factor for Vascular Smooth Muscle Cells General Pharmacology-the Vascular System. ,vol. 31, pp. 1- 8 ,(1998) , 10.1016/S0306-3623(97)00420-5
Kid Törnquist, Elina Ekokoski, Benoit Dugué, PURINERGIC AGONIST ATP IS A COMITOGEN IN THYROID FRTL-5 CELLS Journal of Cellular Physiology. ,vol. 166, pp. 241- 248 ,(1996) , 10.1002/(SICI)1097-4652(199602)166:2<241::AID-JCP1>3.0.CO;2-P
Ling Chen, Hui-ying He, Hong-mei Li, Jie Zheng, Wan-jie Heng, Jiang-feng You, Wei-gang Fang, ERK1/2 and p38 pathways are required for P2Y receptor-mediated prostate cancer invasion Cancer Letters. ,vol. 215, pp. 239- 247 ,(2004) , 10.1016/J.CANLET.2004.05.023
Astrid Hoebertz, Timothy R. Arnett, Geoffrey Burnstock, Regulation of bone resorption and formation by purines and pyrimidines. Trends in Pharmacological Sciences. ,vol. 24, pp. 290- 297 ,(2003) , 10.1016/S0165-6147(03)00123-8
Teri G. Boulton, Steven H. Nye, David J. Robbins, Nancy Y. Ip, Elizabeth Radzlejewska, Sharon D. Morgenbesser, Ronald A. DePinho, Nikos Panayotatos, Melanie H. Cobb, George D. Yancopoulos, ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF Cell. ,vol. 65, pp. 663- 675 ,(1991) , 10.1016/0092-8674(91)90098-J
Milena Romanello, Bianca Pani, Massimiliano Bicego, Paola D'Andrea, Mechanically Induced ATP Release from Human Osteoblastic Cells Biochemical and Biophysical Research Communications. ,vol. 289, pp. 1275- 1281 ,(2001) , 10.1006/BBRC.2001.6124
JACQUELINE VAN SANDE, JACQUES E. DUMONT, ARNE MELANDER, FRANK SUNDLER, Presence and Influence of Cholinergic Nerves in the Human Thyroid The Journal of Clinical Endocrinology and Metabolism. ,vol. 51, pp. 500- 502 ,(1979) , 10.1210/JCEM-51-3-500
Wenzhu Zhang, Brian T. Chait, ProFound: An Expert System for Protein Identification Using Mass Spectrometric Peptide Mapping Information Analytical Chemistry. ,vol. 72, pp. 2482- 2489 ,(2000) , 10.1021/AC991363O
Ming-Tze Tu, Shue-Fen Luo, Chuan-Chawn Wang, Chin-Sung Chien, Chi-Tso Chiu, Chih-Chung Lin, Chuen-Mao Yang, P2Y2 receptor-mediated proliferation of C6 glioma cells via activation of Ras/Raf/MEK/MAPK pathway British Journal of Pharmacology. ,vol. 129, pp. 1481- 1489 ,(2000) , 10.1038/SJ.BJP.0703182